Yalonda Howze serves as Executive at Codiak BioSciences, Inc., where they oversee executive responsibilities. Since joining the company, Yalonda Howze has executed 15 insider transactions totaling $5.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved selling 99 shares valued at $664.
Yalonda Howze currently holds 2,345 shares of Codiak BioSciences, Inc. (CDAK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yalonda Howze has been a net seller of CDAK stock. They have purchased $0 and sold $5.5K worth of shares.
Yalonda Howze's most recent insider trade was on Oct 15, 2025, when they sold 99 shares at $6.71 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 15, 2025 | GBIO | $423 | Payment | 983 | $0.43 | Discretionary |
| Jul 15, 2025 | GBIO | $0 | Option Exercise | 3,347 | $N/A | Discretionary |
| Jul 15, 2024 | GBIO | $2.9K | Payment | 983 | $2.93 | Discretionary |
| Jul 15, 2024 | GBIO | $0 | Option Exercise | 3,347 | $N/A | Discretionary |
| Apr 15, 2024 | GBIO | $14.5K | Payment | 3,930 | $3.70 | Discretionary |
| Apr 15, 2024 | GBIO | $0 | Option Exercise | 13,388 | $N/A | Discretionary |
| Mar 30, 2023 | CDAK | $326 | Sale | 1,628 | $0.20 | Discretionary |
| Feb 17, 2023 | CDAK | $946 | Sale | 1,603 | $0.59 | Discretionary |
| Feb 16, 2023 | CDAK | $0 | Option Exercise | 4,856 | $N/A | Discretionary |
| Jan 20, 2023 | CDAK | $877 | Sale | 1,512 | $0.58 | Discretionary |
| Jan 19, 2023 | CDAK | $0 | Option Exercise | 4,000 | $N/A | Discretionary |
| Aug 17, 2022 | CDAK | $3.3K | Sale | 1,512 | $2.21 | Discretionary |
| Aug 16, 2022 | CDAK | $0 | Option Exercise | 4,857 | $N/A | Discretionary |